- Home
- PRAX
as 07-26-2024 4:00pm EST
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 773.4M | IPO Year: | 2020 |
| Target Price: | $137.38 | AVG Volume (30 days): | 449.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -14.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.90 - $67.21 | Next Earning Date: | 08-07-2024 |
| Revenue: | $2,195,000 | Revenue Growth: | 221.38% |
| Revenue Growth (this year): | -18.76% | Revenue Growth (next year): | -56.61% |
Latest Praxis Precision Medicines Inc. News
PRAX Breaking Stock News: Dive into PRAX Ticker-Specific Updates for Smart Investing
Zacks
10 days ago
C4 Therapeutics (CCCC) Soars 13.7%: Is Further Upside Left in the Stock?
MT Newswires
a month ago
Needham Initiates Praxis Precision Medicines at Buy With $145 Price Target
Zacks
a month ago
Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
Investor's Business Daily
a month ago
Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure
GlobeNewswire
2 months ago
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
2 months ago
This Is Why Praxis Precision Medicines, Inc.'s (NASDAQ:PRAX) CEO Compensation Looks Appropriate
GlobeNewswire
2 months ago
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
Simply Wall St.
2 months ago
We're Hopeful That Praxis Precision Medicines (NASDAQ:PRAX) Will Use Its Cash Wisely
Compare PRAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRAX Praxis Precision Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.